1.
Clin Infect Dis
; 78(4): 855-859, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38059538
RESUMEN
Using multiple national surveillance systems, we found an increase in the incidence of invasive pneumococcal disease during after the relaxation of non-pharmaceutical interventions against COVID-19, which strongly varied by age. Age groups with higher incidence of respiratory syncytial virus and influenza also experienced higher increase in invasive pneumococcal disease incidence, with no change in pneumococcal carriage.